Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing
Minh Sai(Ludwig-Maximilians-Universität München), Daniel Merk(Goethe University Frankfurt)
Cited by 12
Related Papers
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
The Medicinal Chemistry of Caffeine
|Journal of Medicinal Chemistry|2021|116
<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ
|Journal of Medicinal Chemistry|2020|49
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
|Journal of the American Chemical Society|2023|49
Nurr1 Modulation Mediates Neuroprotective Effects of Statins
|Advanced Science|2022|38